Table 2.
C12-20 FAs (based on GC-MS) | Corynomycolates (estimated based on radioactivity and GC-MS) | |
Covalently and noncovalently linked, in the entire cell envelope (whole-cell alkaline hydrolysis) | 9.69 ± 0.2 | 1.79 ± 0.3* |
OM (RMS extract) | 0.39 ± 0.2 | 1.69 ± 0.4† |
Peptidoglycan embedded (released in CMW extract after lysozyme treatment) | 4.8 ± 0.7§ | — |
Covalently bound to the cell wall (released after alkaline hydrolysis of lysozyme-treated delipidated cells) | Negligible | ≥0.22‡ |
IM (CMW extract − RMS extract) | 4.3 ± 0.6 | 0 |
Values are averages from at least six experiments.
*Calculated based on a C12-20 FA-to-corynomycolate ratio of 5.4 ± 0.9.
†Calculated based on a C12-20 FA-to-corynomycolate ratio of 0.23 ± 0.1 for this fraction.
‡Actual values are expected to be slightly higher because of some loss of cells in preceding CMW extractions and lysozyme treatment steps.